Sertraline and Papaverine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordPapaverine
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can, on their own, affect your heart's electrical rhythm in a way doctors call QT prolongation. Sertraline is an antidepressant, and papaverine is used to relax blood vessels. When you take them together, the effects can add up, which may slightly raise the chance of an irregular heartbeat.
This is a theoretical concern, meaning it is based on how the drugs work rather than a lot of real-world reports. Still, it is worth taking seriously. Please don't stop either medicine on your own. Talk with your pharmacist or doctor, who can review your heart health and decide the safest plan for you.
Interaction: Additive QT interval prolongation when sertraline is combined with papaverine, increasing theoretical risk of ventricular arrhythmias (including torsades de pointes).
- Mechanism: Pharmacodynamic additive effect on cardiac repolarization; both agents carry QT-prolonging potential. Neither is a prodrug relevant to this effect.
- Direction: Additive risk (increased combined QT effect).
- Evidence: Theoretical; onset unspecified.
- Severity: Major.
- Management: Avoid coadministration where possible. If both are required, assess baseline and periodic ECG, correct electrolytes (K+, Mg2+), review concomitant QT-prolonging agents, and individualize therapy.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
The combined use of sertraline with this drug should be avoided, since doing so may heighten the likelihood of QT prolongation and/or ventricular arrhythmias1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Your care team can manage this safely. Because both drugs can lengthen the QT interval, the general guidance is to avoid using them together when possible, but this is a decision for your prescriber based on your needs.
- Keep taking both medications as prescribed unless your doctor or pharmacist tells you otherwise.
- Ask your care team whether an alternative to one drug is appropriate for you.
- Your team may monitor you more closely, including checking your heart rhythm (ECG) and electrolytes.
- Report symptoms like fainting, palpitations, dizziness, or a racing heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Sertraline and Papaverine together?
Combining sertraline and papaverine can add up their effects on heart rhythm (QT prolongation), so this pairing is generally avoided; check with your pharmacist or doctor before taking both. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Papaverine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Papaverine interaction managed?
Your care team can manage this safely. Because both drugs can lengthen the QT interval, the general guidance is to avoid using them together when possible, but this is a decision for your prescriber based on your needs. Keep taking both medications as prescribed unless your doctor or pharmacist tells you otherwise. Ask your care team whether an alternative to one drug is appropriate for you. Your… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Papaverine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
Keep reading about Sertraline
Keep reading about Papaverine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist